Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
World-First NHS Test To Curb Transfusion Side-effects For Thousands with Inherited Blood Disorders
The NHS is set to introduce a new genetic blood matching test for thousands living […]
Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Great Britain
Eisai and Biogen announced today that Eisai has submitted a Marketing Authorization Application (MAA) for […]
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
Stereotaxis today announced a global collaboration with Abbott to integrate Abbott’s EnSite™ X EP System […]
Discovery Life Sciences Joins Akoya Biosciences' Global Service Provider Network to Accelerate Immuno-oncology Research
Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, have announced that it has officially […]
Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells
Phio Pharmaceuticals, a clinical-stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to […]
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
Keegan Nees, IMMY, on Fungal Infection Diagnostics
We caught up with Keegan Nees, a Product Marketing Strategist from IMMY, at ECCMID, who discusses […]
NHS Rolls Out New ‘Lifeline’ Combination Therapy for Hundreds of Women With Womb Cancer
Hundreds of women with advanced womb cancer in England are to be offered a new […]
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy™ for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy, a revolutionary new treatment modality for cancer, […]
IN8bio's DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
IN8bio, a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more